Page last updated: 2024-10-25

clofibric acid and Peritonitis

clofibric acid has been researched along with Peritonitis in 1 studies

Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.

Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yokoyama, Y1
Xin, B1
Shigeto, T1
Umemoto, M1
Kasai-Sakamoto, A1
Futagami, M1
Tsuchida, S1
Al-Mulla, F1
Mizunuma, H1

Other Studies

1 other study available for clofibric acid and Peritonitis

ArticleYear
Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:4

    Topics: Alcohol Oxidoreductases; Animals; Anticholesteremic Agents; Apoptosis; Ascites; Cell Line, Tumor; Ce

2007